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Abstract: Cellular metabolism assembles in a structurally highly conserved, but functionally 
dynamic system, known as the metabolic network. This network involves highly active, 
enzyme-catalyzed metabolic pathways that provide the building blocks for cell growth. In 
parallel, however, chemical reactivity of metabolites and unspecific enzyme function give 
rise to a number of side products that are not part of canonical metabolic pathways. It is 
increasingly acknowledged that these molecules are important for the evolution of metabolism, 
affect metabolic efficiency, and that they play a potential role in human disease—age-related 
disorders and cancer in particular. In this review we discuss the impact of oxidative and other 
cellular stressors on the formation of metabolic side products, which originate as a consequence 
of: (i) chemical reactivity or modification of regular metabolites; (ii) through modifications 
in substrate specificity of damaged enzymes; and (iii) through altered metabolic flux that 
protects cells in stress conditions. In particular, oxidative and heat stress conditions are causative 
of metabolite and enzymatic damage and thus promote the non-canonical metabolic activity 
of the cells through an increased repertoire of side products. On the basis of selected examples, 
we discuss the consequences of non-canonical metabolic reactivity on evolution, function 
and repair of the metabolic network. 
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1. Introduction 
During its lifespan, a cell is exposed to many hazards and changes in the environment. These include 
varying pH and temperature, osmotic imbalances, radiation, drought, starvation, contact with deleterious 
or toxic chemicals, or biotic interactions with other species. These stress situations can manifest as an 
acute pulse, or be sustained over time, and can affect cellular functioning and ultimately impair cell 
growth, replicative capabilities, and/or promote aging. Stress-induced damage to biological macromolecules 
such as DNA, proteins and membrane components has been intensively studied and characterized [1–4]. 
However, also cellular metabolites and the flux through metabolic pathways are affected. The impact of 
stress on metabolism and its small-molecule cellular constituents has attracted notable attention in areas 
of chemistry and toxicology [5,6], but only recently research has begun to systemically analyze the  
wide-ranging consequences at the systems level [7,8]. Since metabolism is a basal property of life and a 
main driving force during evolution, being the closest-to-phenotype cellular attribute, and given the 
reactive nature of many metabolites, the identification of stress-related metabolic processes appears to 
be of fundamental importance. 
2. Chemical Damage to Metabolites: Oxidants and Antioxidants 
One of the most important causes of metabolic damage is unspecific oxidation. Basal levels of 
oxidizing molecules arise constantly from normal cellular processes involving redox reactions or in the 
mitochondrial or photosynthetic electron transport chains [9]. Normal levels of oxidants are compensated by 
cellular metabolism, and being integral part of physiology, are required for biochemical reactions and as 
signaling molecules [10]. In a range of conditions referred to as “oxidative stress” [11], normal redox 
homeostasis is however disrupted and the balance between reducing and oxidizing molecules shifts towards 
the latter. Under oxidative stress, reactive oxygen species (ROS) represent one of the most important 
groups of cellular oxidants and comprise oxygen-derived molecules such as hydrogen peroxide (H2O2), 
superoxide anion (O2), or hydroxyl radical (•HO). Non-enzymatic chemical reactivity plays a crucial 
role in this scenario, as for example in the context of the Fe(II)-catalyzed Fenton reaction, that converts 
H2O2 into •HO [12]. Superoxide anion and hydroxyl radical are highly reactive and indiscriminately 
damage metabolites, lipids, enzymes and nucleic acids via peroxidation [13–15]. This damage causes 
“errors” in metabolism [16,17], (Figure 1 (i)) such as the propagation of lipid peroxidation and carbohydrate 
oxidation [18,19]. In addition to the strong potential of superoxide anion to react with transition metals, 
it also combines with other chemical species, e.g., nitric oxide, and generates highly oxidant species 
such as peroxynitrite, causing further damage to lipids, altered nucleobases, and nitration of amino acid 
residues [20–23]. Under oxidative stress, the functionality of cellular systems declines, increasing the risk 
of cellular damage, apoptosis, aging, neurodegeneration and cancer [24–26]. 
Common targets to oxidative damage are amino acids, both in their free and protein integrated forms 
that are both highly abundant. Especially cysteine (which will be discussed later in the text) and methionine 
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are the most prone to oxidation [27]. When the sulphur of methionine reacts with oxidizing molecules, 
it can form methionine-S- or methionine-R-sulfoxides, whose accumulation has been associated with 
various diseases and aging [28,29]. 
 
Figure 1. Formation of non-canonical metabolites and repair strategies. Chemical modification 
of metabolites leads to unwanted reactions, causing damage to both macromolecules and small 
molecules (i). Molecular scavengers cleanse and channel ROS toward less toxic products (ii). 
Stress sensors activate genes involved in specific protein-based repair responses (iii); or in 
unspecific transport processes (iv). As a general outcome, the metabolome reconfigures, 
affecting metabolite levels and fluxes; this in turn affects the specificity of enzymatic 
reactions. (v–vi) Selection of relevant examples from metabolism. Abbreviations: ROS, 
reactive oxygen species; Met, Methionine; GR, glutathione reductase; GSSG, oxidized 
glutathione or glutathione disulfide; GSH, reduced glutathione; MEP, multidrug efflux pump; 
LA, lipid; L•, lipid radical; LOO•, lipid peroxyl radical; R• complex radicals; GLDH, glutamate 
dehydrogenase; -KG, -ketoglutarate; Glu, glutamate; MDH, malate dehydrogenase; OA, 
oxaloacetate; L-2-HG, L-2-hydroxyglutarate; PK, protein kinase; PDC, pyruvate dehydrogenase 
complex; Pyr, pyruvate; Ac-CoA, acetyl-coenzyme A; SerC, phosphoserine transaminase; 
3P-HPyr, 3-phosphohydroxypyruvate; Ser, serine; Ala, alanine.  
Biological systems exploit this property of metabolites and use them as scavengers for ROS. This 
applies not only to methionine and cysteine, but also to pyruvate, -tocopherol, ascorbic acid, or other 
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amino acids [12,30–32] (Figure 1 (ii)). While free methionine acts as general redox buffer, protein-coded 
methionine residues absorb oxidizing agents by positioning on the exposed protein surface and surrounding 
the active site, thereby preventing more severe oxidative damage on targeted proteins [33,34]. This 
oxidation of methionine residues at the protein surface can proceed without significant reduction in enzyme 
activity, as for example in glutamine synthetase, which is shown extremely resistant to H2O2 [33]. 
2.1. Not only Protein and DNA Damage, but also Metabolites Can Be Repaired 
In analogy to DNA and protein repair, cells have developed a series of control mechanisms to cope 
with the oxidized/chemically damaged metabolites, summarized by the term “metabolite repair” [35] or 
“metabolite-damage control” [36–38]. These involve complementary strategies that either: (i) “repair” 
the chemical damage to metabolites (e.g., reversion through reduction of an oxidized molecule); (ii) degrade 
or convert the altered molecules into less harmful products or functional metabolites; or (iii) export the 
non-canonical metabolite. Some of these mechanisms are of general nature and overlap with the parallel 
occurring protein repair mechanisms (e.g., glutathione reductase, thioredoxin). Others are specifically 
targeted against small-molecule derivatives, as for example Glutathione peroxidase 4 (GPx4), which is 
a protein of the glutathione peroxidase (GPx) family with wide substrate specificity, able to reduce a 
variety of lipid hydroperoxides, preventing radical propagation through lipid peroxidation [39,40]. GPx4 
activity obtains its redox potential through the reduced form of the tripeptide glutathione (GSH) [41,42], 
a molecular scavenger which is regenerated in a NADPH-dependent reaction catalyzed by glutathione 
reductase (GR) (Figure 1 (iii)). Indeed, most of the repair mechanisms require, directly or indirectly, 
energy supply in the form of ATP or reducing equivalents [4,15], and many are conditionally activated 
under stress conditions (Figure 1). The consequence is a sudden change of ATP and NADPH consumption 
once cells enter a stress situation and its balance requires metabolism to reconfigure. 
An illustrative example for specific oxidative stress-related repair concerns methionine. Repair of oxidized 
methionine does occur when the amino acid is in its free form as well as when it is part of a protein [43,44] 
(Figure 2). Three enzyme families of methionine sulfoxide reductases, MsrA, MsrB and MsrC, metabolize 
the derivatives in a stereospecific manner. Of them, MsrA and MsrB are highly conserved and reduce the  
S-sulfoxide and the R-sulfoxide residues, respectively, predominantly within a protein context [45]. MsrC 
(also named fRMsr) is only present in prokaryotes [46] and in some eukaryotes [47], and has its main affinity 
for free methionine-R-sulfoxide. Interestingly, MsrC exhibits no sequence homology with MsrA and MsrB, 
indicating independent evolutionary origin of these functionally overlapping proteins. In higher plants, 
where no specific MsrC-like activity exists, the repair function on free methionine-R-sulfoxide is efficiently 
covered by a subtype of MsrB proteins (which would have evolved by segmental duplication) [48], 
evidencing the evolution of alternative adaptive strategies to cope with a similar type of damage (Figure 2). 
As a common observation, repair mechanisms appear widely distributed, irrespective of whether metabolic 
damage proceeds through direct metabolite oxidation, non-enzymatic reactivity, enzyme inactivation,  
or enzyme promiscuity. Although most of these repair functions are non-essential under normal 
conditions, the respective mutants commonly show growth defects, lower survival rates or higher 
mutation frequencies [36,37,47,49,50]. In humans, deficiencies in metabolite detoxification systems are 
related to encephalopathic disorders [51], cancer predisposition [52], drug intolerance [53], or aging and 
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a decreased lifespan [54]. Evidence has also been presented that neuronal clearance of toxic metabolites 
could be the explanation of why metazoans require sleep [55]. 
 
Figure 2. Oxidative damage on methionine and its repair enzymes. Methionine is oxidized 
to methionine-S-sulfoxide and methionine-R-sulfoxide derivatives. Three families of methionine 
sulfoxide reductases (Msr, different colors), revert the process depending on thioredoxin, 
each being stereo-specific against the R- or the S-enantiomeric form. While MsrA and MsrB 
are highly conserved with preference for protein integrated methionine sulfoxides, MsrC 
(fRMsr) is limited to unicellular organisms and reduces free methionine-R-sulfoxide. MsrB 
has evolved by duplication and divergence (red dashed arrows), accounting for coverage of 
diverse subcellular localizations, and enabling in plants the appearance of a subtype active 
against the free methionine-R-sulfoxide. Color intensities illustrate different strength in 
catalytic efficiency. 
2.2. Other Forms of Metabolite Damage: Examples of Nucleotide and Cofactor Metabolism 
Metabolism comprises a large diversity of molecules. The spectrum of possible combinatorial reactions 
and modifications on metabolites extends to a huge space of chemical reactions. Some modifications 
occur however more frequent than others. For instance, nucleotide metabolism is by its nature composed 
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of many metabolites possessing high structural similarities. A range of abnormal nucleotides is generated 
as a consequence of spontaneous oxidation [56]. Others arise from unspecific enzymatic activities, as 
for example by methylation of nucleobases. Several of these aberrant compounds with only slight 
structural differences from the standard bases, can subsequently be recognized by downstream enzymes 
which propagate the error via incorporation. The mischarge of nucleoside diphosphate (NDP) kinases, 
which can promiscuously accept a broad range of base-differing substrates, releases abnormal NTPs that 
cause mispairing and mutagenesis if incorporated into DNA [56,57]. Cells have developed various 
families of NTP pyrophosphatases that intercept and hydrolyze non-canonical NTPs [37]. For instance, 
MutT-like proteins of the widespread Nudix superfamily catalyze—with variable degree of substrate 
specificity—the detoxification of oxo-purine dNTPs generated during oxidative stress, and thereby 
prevent DNA damage [58–60]. In other cases, substrate promiscuity (which will be discussed in more 
detail below) is the main contributor to the pool of abnormal nucleotides: dUTPases hydrolyze with high 
specificity dUTP, discriminating against normal cytosine and thymine nucleobases. dUTP can arise from 
UDP through a secondary activity of ribonucleotide reductase followed by phosphorylation, or by (catalytic) 
deamination of a deoxycytidine (tri-)phosphate. Interestingly, this principle of dUTPase activity is present 
in all three kingdoms of life, but is fulfilled by two mutually exclusive dUTPase families that present no 
sequence homology, yet being functionally analogous [61,62]. 
Another quantitatively highly relevant case concerns chemical modification of enzymatic 
coenzymes, such as NADH or FADH. Hydration of NADH or NADPH is common, occurring either 
non-enzymatically [63] or as a side reaction of promiscuous enzymes such as glyceraldehyde 3-phosphate 
dehydrogenase [64]. The resulting R and S hydrated forms of NAD(P)H display high structural similarity 
with the cofactors but are non-functional and inhibit various dehydrogenase reactions [65]. An 
ADP/ATP-dependent NAD(P)H dehydratase, widespread in all domains of life, converts the S enantiomeric 
derivative back to NAD(P)H [63]. Its action is complemented by the catalytic activity of an epimerase 
that catalyzes the interconversion between the R and S hydrated forms, an enzyme that appears fused to 
the dehydratase in some species such as Escherichia coli. Interestingly, in higher plants [66,67] and also 
in mammals [68] both genes possess organellar targeting sequences, allowing the proteins to be directed 
and co-localize within diverse subcellular compartments. 
3. Non-Enzymatic Metabolic Reactions Are Affected by Stress Conditions 
A second aspect of the susceptibility of metabolism concerns non-enzymatic reactions that occur as 
part of normal metabolism or through non-specific chemical reactivity but that contribute to canonical 
metabolic pathways [69,70]. Such non-enzymatic reactions are of high importance for the evolution of 
metabolism, as exemplified by the metabolism-like non-enzymatic interconversions that can occur 
between central carbon metabolites, which might have given rise to the early evolution of glycolysis and 
pentose phosphate pathway [71]. The presence of an enzyme catalyst in modern cells does however not 
prevent these non-enzymatic chemical reactions to occur in parallel to the enzymatic pathways. Termed 
Class I non-enzymatic metabolic reactions, a subset of non-enzymatic reactions are of low substrate 
specificity and can affect multitude of metabolites and modify a series of macromolecules [69]. These 
include Maillard reactions, unspecific conjugations of amino acids that are accelerated under heat  
and UV exposure, and also unspecific protein modifications such as protein (poly-)phosphorylation, 
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glycosylation or acylation. The term “underground metabolism” [70] has been suggested to summarize 
the repertoire of this chemical reactivity, both non-enzymatic and enzyme-promiscuous, occurring in 
parallel to the flux of functional metabolic pathways. This reactivity is distinguishable from other more 
specific non-enzymatic reactions that are part of the metabolic network, and occur either exclusively 
non-enzymatically (Class II non-enzymatic metabolic reactions) or in parallel to existing enzyme 
function (Class III) [69]. 
Non-enzymatic reactions are dependent on the chemical environment (metal availability, pH, temperature, 
ionic strength), and must therefore be particularly sensitive to stress conditions. This is well illustrated 
for the case of non-enzymatic protein acylation: A number of essential, endogenous thioester metabolites, 
such as acetyl-CoA or succinyl-CoA, can unspecifically cross-acylate protein lysines [72,73]. Protein 
acylation appears most prominent in mitochondria, correlates with the levels of these reactive metabolites 
and with mitochondrial energy-metabolism, and has been linked to a form of “carbon stress” [74].  
Non-enzymatic modification of macromolecules can alter protein function and may require quality-control 
responses. In this case, the sirtuin family of deacetylase enzymes (which has received notable attention 
by a potential connection to the benefits arising from a calorie-restriction diet) has been proposed to 
counteract the potential deleterious effects of non-enzymatic protein acylation and thus to play a role in 
stress resistance [74]. Similarly, for small molecules, intermediates generated in non-enzymatic reactions 
can, if accumulated, interfere with metabolic pathways by acting as competitive inhibitors of enzymes, 
or serve as alternative substrates, and thus need to be cleared. 
While specific repair mechanisms might have evolved for non-canonical metabolites which are 
produced in higher quantities or present strong cytotoxic effects, it is reasonable to assume that not all 
metabolic side products possess specific clearance mechanisms. This becomes illustrative, as the number 
of potential chemical reaction products from non-enzymatic reactivity exceeds the number of enzymes 
encoded in a typical genome by several orders of magnitude. A broad range of metabolites, including 
especially those for which no specific cleaning enzyme exists [75–77], might however be cleared via 
unspecific cellular export, which is largely mediated by efflux pumps and transmembrane channels such 
as multidrug transporters (Figure 1 (iv)). In bacteria, numerous studies report the involvement of 
membrane transporters in multidrug resistance [78–80]. E. coli’s resistance to a high number of compounds 
is mediated by the outer-membrane pore-forming protein TolC [81]. This transporter acts in concert with the 
inner membrane TolC-dependent efflux pump AcrB and with cognate periplasmic proteins (e.g., AcrA) 
to form tripartite trans-periplasmic exporters that push xenobiotics out of the cell [82,83]. There is 
growing evidence suggesting that TolC-mediated extrusion is not limited to xenobiotics [84]: E. coli 
tolC mutants show lower fitness phenotypes in certain stress conditions [85], accumulate cell-synthesized 
enterotoxins and potentially-deleterious intermediary metabolites [86], and overexpress key stress 
response regulators, presumably triggered by the abnormal retention of toxic cellular products [87]. 
Similar transport mechanisms operate in many other bacteria [80]. 
4. Enzymes That Change Substrate Specificity during Stress Conditions 
A third important aspect of metabolism during stress conditions does not concern the direct chemical 
modification of metabolites, but affects them indirectly by altering enzyme function. Upon damage, several 
enzymes decrease in substrate specificity and simultaneously increase in promiscuity. When enzymes 
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are modified, novel subsidiary activities and interactions can arise concomitantly from the altered 
proteins, enabling additional metabolic reactions, some of potential physiological significance [70,88]. 
It is a general property of metabolism that most metabolic enzymes are not as specific as sometimes 
depicted in textbooks, and are in fact error-prone or ambiguous in their function [89,90] (Figure 3) (The 
concept of “enzyme promiscuity” has been massively used recently, but in different contexts and with 
different meanings [91]. The classification that we make below follows that by Hult and Berglund [91].). 
 
Figure 3. Mechanistic classification of enzyme promiscuity. (A) Substrate promiscuity or 
multispecificity: A certain enzyme can perform the same catalytic reaction on a diverse set 
of substrates indistinctly; (B) Catalytic promiscuity: Different chemical transformations are 
allowed by the same enzyme, according to which this can be classified with various E.C. 
numbers. (C) Conditional promiscuity: Latent secondary activities of an enzyme might gain 
activity in response to environmental changes, e.g., due to an increase in the concentration 
of substrate analogs with lower affinity for the enzyme, or by post-translational signals related 
with induced conformational changes. The three examples shown are merely illustrative but 
inspired by transaminase TyrB, cytosine methyltransferase and thymidine kinase, respectively. 
Most enzymes accept multiple substrates and possess affinities for a wider range of compounds, a 
phenomenon referred to as substrate promiscuity (Figure 3A) (Some authors consider that the capacity 
of an enzyme to catalyze various natural substrates may be more conveniently described by the term 
“substrate multispecificity” or “cross-reactivity”, so that the term “substrate promiscuity” is reserved to 
adventitious secondary activities different from the one the enzyme has evolved: see [90,92].). A recent 
example of notable attention is the enzyme TP53-induced glycolysis and apoptosis regulator (TIGAR), 
an enzyme that possesses an important role in cancer cell metabolism. TIGAR was first identified as 
fructose-2,6-bisphosphatase (F26BPase) [93], but it accepts multiple substrates. TIGAR shows its highest 
activity as phosphoglycolate-independent 2,3-bisphosphoglycerate phosphatase [94], acting most efficiently 
on a metabolite whose function is so far unclear. 
Biomolecules 2015, 5 2109 
 
 
Other enzymes are able to catalyze more than one type of chemical reaction on a given set of substrates 
(catalytic promiscuity, Figure 3B). This is the case of certain cytosine methyltransferases that are able to 
catalyze cytosine methylation as well as cytosine deamination. Cytosine deamination yields thymine, 
implying that this catalytic activity causes mutations and could play a potential role in tumourogenesis [95]. 
A classical example of enzymes that possess promiscuous activities that can lead to toxic by-products 
are malate dehydrogenase (MDH) and isocitrate dehydrogenase (IDH1 and IDH2). MDH typically 
catalyzes the interconversion between malate and oxaloacetate, but possesses certain affinity towards  
-ketoglutarate. Despite the much higher affinity for the canonical substrate, high intracellular levels of 
-ketoglutarate promote that MDH also produces L-2-hydroxyglutarate (see conditional promiscuity, 
Figure 1 (v), Figure 3C) [35]. A widely distributed FAD-dependent enzyme, the L-2-hydroxyglutarate 
dehydrogenase, specifically converts this side-product back into -ketoglutarate [36]. Deleterious mutations 
in this enzyme in humans are responsible for an inherited metabolic disease called L-2-hydroxyglutaric 
aciduria, attributed to the accumulation of the aberrant product [51]. An analogous detoxification system 
exists also for its enantiomer D-2-hydroxyglutarate [96]. This normal metabolic intermediate is overproduced 
by mutant forms of isocitrate dehydrogenase-1 and -2 (IDH1 and IDH2) [97]. These mutations, preferentially 
occurring in cancer, alter the enzyme towards an increased production of this metabolite, which is 
otherwise formed in a side reaction and at a low rate only. D-2-hydroxyglutarate is also found at increased 
levels in patients suffering from the metabolic syndrome D-2-hydroxyglutaric aciduria [98], a genetically 
heterogeneous neurometabolic disorder attributed to germline mutations in IDH2 [99] and mutant 
genotypes of the D-2-hydroxyglutarate dehydrogenase, the enzyme responsible for D-2-hydroxyglutarate 
repair [98]. 
Importantly, such secondary activities of enzymes are often latent in normal growth conditions, but 
can become relevant in response to environmental changes or stresses (conditional promiscuity, Figure 3C), 
either by: (i) an enhanced bioavailability of a low-affinity substrate analog in comparison with the 
concentration of the natural substrate; (ii) conformational (allosteric) changes of the enzyme induced by 
direct exposure to stressors; (iii) conformational changes regulated by specific post-translational 
modifications exerted by stress-related signaling pathways. Therefore, enzyme promiscuity must be of 
critical importance for an integral view of metabolic reconfiguration under stress conditions (Figure 1). 
An illustrative case is represented by metalloenzymes that exhibit a tendency toward mis-metallation 
during stress conditions. The activity of most metalloproteins depends on the binding of the correct 
metal, with a mis-metallation resulting in change of reactivity, or partial to total inactivation. Bacterial 
ribulose 5-phosphate epimerase (Rpe) and some other enzymes that are canonically iron-dependent, 
actually accept both iron Fe(II) and manganese Mn(II) as cofactor [100,101]. As pointed out by Cotruvo 
and Stubbe [102], Fe(II)- and Mn(II)- binding affinities are comparable in these proteins, and thus the 
discrimination between both metals is roughly determined by the differential bioavailability. While the 
enzymes are hence bound to Fe(II) under normal cellular growth conditions, they appear charged with 
Mn(II) under oxidative stress or iron-limiting conditions. This ambiguity is regarded as an adaptive 
strategy to protect enzymes from irreversible inactivation and severe damage [100] (Table 1): (i) Fe(II) 
centers are sensitive to ROS and oxidize to Fe(III), causing enzyme inactivation [101]; (ii) free iron 
pools react with ROS propagating the toxic free radical formation [103]. Interestingly, the same 
transcriptional control mechanisms that are responsible to ensure iron sequestration and control during 
oxidative stress [103] are linked to Mn(II) import and the promotion of the Mn metabolism [102]. 
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Noteworthy, Mn(II), when bound to phosphate or carbonate, can act as an efficient non-enzymatic catalyst 
for the superoxide disproportionation at physiological conditions [104], which can in fact rescue yeast 
superoxide dismutase-knockouts [105], conferring an additional role to Mn(II) as antioxidant. 
Adaptive Promiscuity: When Altered Substrate Specificity Becomes Advantageous 
Despite being an energetic burden to the cell, promiscuity and multi-substrate specificity is an integral 
biological property in metabolic networks, and is essential as it is necessary for the evolution of 
metabolism [106]. In some instances, the ability to process multiple substrates is beneficial to cells in 
stress situations (Table 1). Perhaps one of the most illustrative examples is the genetic code “ambiguity”. 
Translational fidelity, and thus an adequate protein biosynthesis, relies on the accurate aminoacylation of the 
different tRNA molecules by specific aminoacyl-tRNA synthetases and on unambiguous codon-anticodon 
pairing within the ribosome. Yet a certain degree of permissiveness is known to exist due to nucleobase 
wobbling, accounting for the degeneracy in the genetic code. Indeed, numerous exceptions and variants to 
the standard decoding have been reported in different organisms [107–109]. Netzer et al. [110] demonstrated 
how the genetic code accuracy can also change within the lifespan of an individual cell, as a consequence 
of induced changes in the acylation fidelity of aminoacyl-tRNA synthetases. A small but significant 
amount of methionine (Met) residues (approximately 1% of all coded Met) misacylate to non-cognate 
tRNA in normal unstressed mammalian cells. This fraction sharply increases (to approximately 13%) 
under ROS-related stress conditions, for example when exposing cultured cells to viral infections, 
bacterial wall factors or physico-chemical stressors. This results in proteins with high content in 
mistranslated Met. As discussed above, Met is a biological scavenger of ROS, proposing an adaptive 
role of methionyl-tRNA synthetase (MetRS) promiscuity and controlled Met-misacylation in coping 
with oxidative damage (Table 1). A recent study [111] reveals that the modulation of MetRS specificity is 
mediated by particular serine phosphorylations driven by the protein kinase ERK, which is a common 
mediator in the signaling response to stress. This represents a further indication about the in vivo 
protective role of Met-misincorporation for cell survival and growth under ROS stress. 
The antioxidant function of Met residues might be also the cause of AUA codon reassignment in 
mitochondria, from isoleucine (Ile) to Met, which is widespread in vertebrates and also occurs in several 
invertebrates with a highly aerobic metabolism (like insects) and in some unicellular eukaryotes, 
including Saccharomyces cerevisiae [112]. With the respiratory chain as continuous source of ROS, one 
might hypothesize that a permanent redefinition of the genetic code (with one extra codon assigned to 
Met, and 2 instead of 3 codons for Ile) could have been a more suitable evolutionary adaptation in 
mitochondria than an inducible mechanism to tune promiscuous methionylation activities on non-methionyl 
tRNAs. Integral proteins of the mitochondrial inner membrane are overloaded with Met on their exposed 
surfaces (a classical preferential position for Ile residues), and in this way a significant containment of 
oxidative damage is achieved [112]. 
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Table 1. Possible physiological benefits of various promiscuous and redundant activities 
induced in response to stress or environmental changes. 
Stress Enzyme Induced Activity Alleged Function Reference 
Oxidative stress Mammalian MetRS 
Mismethionylation of 
non-cognate tRNAs 
Protect enzymes 
from inactivation 
[110] 
Biotic interaction 
SerRS/LeuRS  
from Candida 
Misleucinylation  
of Ser-tRNA 
Increased invasivity, 
immune invisibility 
[113] 
Biotic interaction, 
anaerobiosis, starvation... 
Bacterial transaminases 
Redundancy in Ala &  
Lys biosynthesis 
Robust 
peptidoglycan 
biosynthesis 
[114] 
Oxidative stress 
Bacterial 
Pentosephosphate 
epimerase (Rpe) 
Mismetallation  
with Mn(II) 
Protect enzymes 
from inactivation 
[102] 
Another case in which ambiguous tRNA acylation has been proven beneficial is that of the fungus 
Candida albicans [115] (Table 1). Here the codon CUG can be translated both as a leucine (Leu) and as a 
serine (Ser) (with 5% and 95% frequency, respectively). This duality arises from the capacity of two 
aminoacyl-tRNA synthetases (LeuRS and SerRS) to recognize the particular unique serine tRNA (CAG) 
and allows statistically distributed populations of different mistranslated proteins from the same gene. 
This increase in phenotypic diversity is exploited in pathogenicity [113]. In fact, genes encoding cell 
surface adhesins are especially rich in CUG codons: partial CUG mistranslation as Leu results in 
morphological variations and heterogeneity in the cell wall that modify Candida interactions with the 
host microenvironment. In particular, experimental evidence shows that adherence capacities improve 
while recognition by the hosts immune system decreases [113], both being related with Candida virulence. 
5. Changing Activity and Metabolic Switches: Stress Situations That Affect Flux Distribution 
Enzyme activities are tunable and the degree of affinity and/or efficiency (Km, kcat) for different 
metabolites may change according to conditions [91] (Figure 3C). This also applies during the individual 
lifetime of an enzyme, e.g., due to age related conformational alterations [116]. As a consequence, aside from 
the immediate effects of protein damage on the enzymes natural function and its promiscuous activities, 
the inactivation of a metabolic enzyme commonly involves an adaptation in total metabolic flux and/or 
results in a redistribution of flux toward other pathways. Due to its redox capacity, cysteine plays a 
pivotal role in many enzyme catalytic mechanisms, and the redox sensitivity of this amino acid renders 
several enzymes vulnerable to redox imbalances and ROS accumulation [27,117,118]. Interestingly, this 
redox sensitivity is exploited by cells to intensify metabolic protection in stress situations. In yeast, two 
enzymes of glycolysis, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and pyruvate kinase 
(PK), have been shown to be sensitive to oxidation, leading to a rapidly induced (in seconds-scale) but 
temporal glycolytic block [119,120]. Termed the glycolysis/PPP transition, the oxidative part of the pentose 
phosphate pathway (PPP) that is more redox resistant, increases in activity, resulting in enhanced NADPH 
production under the conditions where this cofactor is required by the anti-oxidant machinery [119,121]. 
The inactivation of GAPDH during oxidative stress is not only an adverse side reaction; the enzyme 
possesses evolved structural features that compete for free H2O2 to assure rapid inactivation when levels 
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of this metabolite rise [122]). Increased PPP activity and stress resistance augmentation in yeast are also 
observed when the activities of triosephosphate isomerase [123] and pyruvate kinase [124,125] are 
reduced by genetic modification, implying that increased NADPH production in the oxidative PPP is a 
recurrent consequence to blocks in glycolysis. Recently, time-resolved metabolomics has revealed this 
mechanism to be conserved in mammalian skin cells, revealing however that the mechanistic trigger of 
the glycolytic/PPP transition is not yet understood [126]. In this context, it is however important to keep 
in mind that the contribution of distinct metabolic pathways, including the oxidative PPP, to the total 
NADPH pool differs between yeast and mammalian cell types, and even between tissues [127], so that 
the individual cells and organisms may distribute NADPH production in a different manner. 
Another oxidant-induced change in metabolic flux distribution is connected to the polyamine metabolites 
spermine, spermidine and putrescine. These polycations are implicated in a multitude of cellular functions, 
including the stress response [128]. Treatment with peroxides affects the intracellular concentrations of 
spermidine and putrescine in correlation with the expression of the polyamine transporter TPO1 [129]. 
Yeast cells overexpressing this transporter are sensitive to oxidants and are unable to induce canonical 
stress response proteins, such as HSP70 or HSP104. Effects of the transporter overexpression on metabolite 
levels are only detected upon application of the oxidant; stress-induced transport of these metabolites thus 
appears critical for the interaction of the metabolome and the proteome in stress situations [129]. In this 
respect, polyamine catabolism has attracted attention as a potential contributor to cytotoxicity, with H2O2 
being a product of polyamine oxidation [130]. Studies in human breast cancer cell lines demonstrate the 
involvement of the polyamine degradative enzyme spermine oxidase SMO (PAOh1) in the production of 
H2O2 upon induction by a spermine analogue [131]. Overexpressing SMO leads to sub-lethal DNA damage 
and this confers sensitivity to radiation [132,133]. 
6. Evolution and the Impact of Metabolic Inaccuracy on the Genotype to Phenotype Relationship 
Carbonell et al. [134] implies that promiscuous enzymes are widespread in the phylogenetic tree of 
life and appear statistically more shared across species (allegedly more ancient) than specific ones, 
consistent with the hypothesis of an evolutionary trend toward the specialization of enzymes [135,136]. 
The different levels of specificity of current metabolic enzymes would have evolved by segmental 
duplication of previously promiscuous protein-coding genes. Enzymes would diverge at different rates 
depending on trade-offs and selective pressures over their particular function and the environmental 
context [106]. Interestingly, the content in promiscuous and unspecific enzymes differs between organisms 
and correlates with their ecology; taxonomic groups facing stronger environmental changes possess more 
promiscuous enzymes [134]. Recently, evidence has been provided that a fraction of latent enzymatic 
side activities maps to functional products of the existing metabolic network, and confers advantage 
under novel growth environments [137]. 
Also metabolite repair—potentially in the form of much more rudimentary mechanisms—might date 
back to the very early stages of evolution and could already have been important for the development of 
metabolism during the origin of life [138], as first metabolic networks likely required mechanisms to 
achieve a minimally robust functioning [139]. During subsequent evolution, non-enzymatic reactions 
and enzyme promiscuity did contribute to the increase in the phenotypic variability of a cell. Persisting 
in modern cells, metabolic ambiguity is to be added to the sources of variation at the transcriptional and 
Biomolecules 2015, 5 2113 
 
 
translational levels, required to understand the genotype-to-phenotype relationship (Figure 4): During 
the flow of information from gene over protein to metabolite, errors and variability are propagated, 
increasing the spectrum of phenotypes to be reached from the same genotype. Whereas most of these 
variants may involve a fitness cost for a well-adapted organism, flexibility facilitates adaptation when 
conditions change (Figure 4). 
 
Figure 4. Impact of metabolic inaccuracy on the genotype-to-phenotype relationship. Biological 
processes, including transcription, translation and metabolism are not totally accurate. During 
the gene-protein-metabolite information flow, errors generated at each operational layer that 
are not compensated (depicted as angles , , ) propagate, overall shaping the phenotypic 
space to be achieved from the same genotype (variation in the x-axis). Phenotypic variability 
arising due to error propagation can be enhanced by environmental stress conditions and enables 
a wide space of positions in the fitness landscape (red curve), all of which contribute to define 
the selection pressure over the given genotype (A). Promiscuity, noise, and unspecificity may 
thus facilitate the physiological adaptation to changing conditions, which would otherwise 
require the evolution to a different genotype (B). 
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7. Conclusions 
With the advent of systems biology and analytical techniques that allow analyzing multiple cellular 
metabolites in parallel, it has become clear that metabolism is constituted by a highly dynamic network. 
In this short review, we discuss examples that reveal the impact of stress conditions on metabolites, 
metabolic reactions and metabolic flux. Non-enzymatic reactions, chemical reactivity between metabolites, 
and enzyme promiscuity are inevitable consequence of the chemical properties of essential metabolites, 
and mechanistic and structural constraints of the participating enzymes. In stress conditions, these factors 
play synergetic roles in the propagation of errors and damage within metabolism, but also form the basis 
to reconfigure metabolism so that cells can adapt to changing or stress-inducing environments [90,140]. 
Metabolism in stress situations appears to be mainly affected by: (i) direct chemical modification of 
metabolites; or (ii) damage on enzymes that change their substrate specificity and/or catalytic activity. 
Temporary blockage of metabolic pathways translates as changes in the metabolic flux distribution. 
Although stress situations appear to be deleterious in the first instance, they have been exploited by 
evolution to extend the metabolic network, and to develop dynamic response mechanism to cope with 
changes in the environment. This includes either the use of promiscuous metabolites in signaling, so that 
repair and damage responses are initiated and function as stress sensors [10,27,141], or direct defense systems 
that involve stress-induced redistribution of the metabolic flux [70,119,120]. Finally, enzyme conditional 
promiscuity acts as a reservoir of new functions that can evolve into tunable mechanisms [142], with 
some of the non-canonical metabolites turning out to be useful [70,106,143–145]. Metabolism during 
stress conditions thus changes in activity, structure and complexity; and contributes to evolution, phenotype, 
and survival in stress situations. 
Acknowledgments 
We thank our lab-members for critical discussion. Work in the Ralser lab is funded from the Wellcome 
Trust (RG 093735/Z/10/Z), the ERC (Starting grant 260809). Markus A. Keller is supported by the Austrian 
Science Funds by an Erwin Schrödinger postdoctoral fellowship (FWF, J 3341). Markus Ralser is a 
Wellcome Trust Research Career Development and Wellcome-Beit Prize fellow. 
Author Contributions 
Gabriel Piedrafita, Markus A Keller and Markus Ralser have written this Review article. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Van Houten, B. Nucleotide excision repair in Escherichia coli. Microbiol. Rev. 1990, 54, 18–51. 
2. Mary, J.; Vougier, S.; Picot, C.R.; Perichon, M.; Petropoulos, I.; Friguet, B. Enzymatic reactions 
involved in the repair of oxidized proteins. Exp. Gerontol. 2004, 39, 1117–1123. 
3. Perrone, G.G.; Tan, S.-X.; Dawes, I.W. Reactive oxygen species and yeast apoptosis. Biochim. 
Biophys. Acta 2008, 1783, 1354–1368. 
Biomolecules 2015, 5 2115 
 
 
4. Morano, K.A.; Grant, C.M.; Moye-Rowley, W.S. The response to heat shock and oxidative stress 
in Saccharomyces cerevisiae. Genetics 2012, 190, 1157–1195. 
5. Harman, D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11, 
298–300. 
6. Sies, H. Biochemistry of oxidative stress. Angew. Chem. Int. Ed. Engl. 1986, 25, 1058–1071. 
7. Liu, J.; Litt, L.; Segal, M.R.; Kelly, M.J.S.; Pelton, J.G.; Kim, M. Metabolomics of oxidative stress 
in recent studies of endogenous and exogenously administered intermediate metabolites. Int. J. 
Mol. Sci. 2011, 12, 6469–6501. 
8. Noctor, G.; Lelarge-Trouverie, C.; Mhamdi, A. The metabolomics of oxidative stress. Phytochemistry 
2014, 112, 33–53. 
9. Ott, M.; Gogvadze, V.; Orrenius, S.; Zhivotovsky, B. Mitochondria, oxidative stress and cell death. 
Apoptosis 2007, 12, 913–922. 
10. D’Autréaux, B.; Toledano, M.B. ROS as signalling molecules: Mechanisms that generate 
specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8, 813–824. 
11. Sies, H. Oxidative stress: A concept in redox biology and medicine. Redox Biol. 2015, 4C, 180–183. 
12. Valko, M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and oxidative stress. Curr. Med. Chem. 
2005, 12, 1161–1208. 
13. Du, J.; Gebicki, J.M. Proteins are major initial cell targets of hydroxyl free radicals. Int. J. Biochem. 
Cell Biol. 2004, 36, 2334–2343. 
14. Liu, C.-C.; Gebicki, J.M. Intracellular GSH and ascorbate inhibit radical-induced protein chain 
peroxidation in HL-60 cells. Free Radic. Biol. Med. 2012, 52, 420–426. 
15. Davies, K.J. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement 
systems. IUBMB Life 2000, 50, 279–289. 
16. Halliwell, B.; Gutteridge, J. Free Radicals in Biology and Medicine; 4th ed.; Oxford University 
Press: Oxford, OX, USA, 2007. 
17. Breen, A.P.; Murphy, J.A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 1995, 18, 
1033–1077. 
18. Gilbert, B.C.; King, D.M.; Thomas, C.B. Radical reactions of carbohydrates. Part 2. An electron 
spin resonance study of the oxidation of D-glucose and related compounds with the hydroxyl radical. 
J. Chem. Soc. Perkin Trans. 1981, 2, 1186–1199. 
19. Manini, P.; la Pietra, P.; Panzella, L.; Napolitano, A.; d’Ischia, M. Glyoxal formation by Fenton-induced 
degradation of carbohydrates and related compounds. Carbohydr. Res. 2006, 341, 1828–1833. 
20. Arteel, G.E.; Briviba, K.; Sies, H. Protection against peroxynitrite. FEBS Lett. 1999, 445, 226–230. 
21. Sawa, T.; Akaike, T.; Maeda, H. Tyrosine nitration by peroxynitrite formed from nitric oxide and 
superoxide generated by xanthine oxidase. J. Biol. Chem. 2000, 275, 32467–32474. 
22. Klotz, L.-O.; Schroeder, P.; Sies, H. Peroxynitrite signaling: Receptor tyrosine kinases and activation 
of stress-responsive pathways. Free Radic. Biol. Med. 2002, 33, 737–743. 
23. Klotz, L.-O.; Sies, H. Defenses against peroxynitrite: Selenocompounds and flavonoids. Toxicol. Lett. 
2003, 140–141, 125–132. 
24. Williams, T.I.; Lynn, B.C.; Markesbery, W.R.; Lovell, M.A. Increased levels of 4-hydroxynonenal 
and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment 
and early Alzheimer’s disease. Neurobiol. Aging 2006, 27, 1094–1099. 
Biomolecules 2015, 5 2116 
 
 
25. Pamplona, R. Membrane phospholipids, lipoxidative damage and molecular integrity: A causal 
role in aging and longevity. Biochim. Biophys. Acta 2008, 1777, 1249–1262. 
26. Thanan, R.; Oikawa, S.; Hiraku, Y.; Ohnishi, S.; Ma, N.; Pinlaor, S.; Yongvanit, P.; Kawanishi, S.; 
Murata, M. Oxidative stress and its significant roles in neurodegenerative diseases and cancer.  
Int. J. Mol. Sci. 2015, 16, 193–217. 
27. Cremers, C.M.; Jakob, U. Oxidant sensing by reversible disulfide bond formation. J. Biol. Chem. 
2013, 288, 26489–26496. 
28. Moskovitz, J. Methionine sulfoxide reductases: Ubiquitous enzymes involved in antioxidant 
defense, protein regulation, and prevention of aging-associated diseases. Biochim. Biophys. Acta 
2005, 1703, 213–219. 
29. Stadtman, E.R.; van Remmen, H.; Richardson, A.; Wehr, N.B.; Levine, R.L. Methionine oxidation 
and aging. Biochim. Biophys. Acta 2005, 1703, 135–140. 
30. O’Donnell-Tormey, J.; Nathan, C.F.; Lanks, K.; DeBoer, C.J.; de la Harpe, J. Secretion of 
pyruvate. An antioxidant defense of mammalian cells. J. Exp. Med. 1987, 165, 500–514. 
31. Troxell, B.; Zhang, J.-J.; Bourret, T.J.; Zeng, M.Y.; Blum, J.; Gherardini, F.; Hassan, H.M.;  
Yang, X.F. Pyruvate protects pathogenic spirochetes from H2O2 killing. PLoS ONE 2014, 9, e84625. 
32. Rose, R.C.; Bode, A.M. Biology of free radical scavengers: An evaluation of ascorbate. FASEB J. 
1993, 7, 1135–1142. 
33. Levine, R.L.; Mosoni, L.; Berlett, B.S.; Stadtman, E.R. Methionine residues as endogenous 
antioxidants in proteins. Proc. Natl. Acad. Sci. USA 1996, 93, 15036–15040. 
34. Luo, S.; Levine, R.L. Methionine in proteins defends against oxidative stress. FASEB J. 2009, 23, 
464–472. 
35. Rzem, R.; Vincent, M.-F.; van Schaftingen, E.; Veiga-da-Cunha, M. L-2-hydroxyglutaric aciduria, 
a defect of metabolite repair. J. Inherit. Metab. Dis. 2007, 30, 681–689. 
36. Linster, C.L.; van Schaftingen, E.; Hanson, A.D. Metabolite damage and its repair or pre-emption. 
Nat. Chem. Biol. 2013, 9, 72–80. 
37. Galperin, M.Y.; Moroz, O.V.; Wilson, K.S.; Murzin, A.G. House cleaning, a part of good 
housekeeping. Mol. Microbiol. 2006, 59, 5–19. 
38. Van Schaftingen, E.; Rzem, R.; Marbaix, A.; Collard, F.; Veiga-da-Cunha, M.; Linster, C.L. 
Metabolite proofreading, a neglected aspect of intermediary metabolism. J. Inherit. Metab. Dis. 
2013, 36, 427–434. 
39. Ursini, F.; Maiorino, M.; Brigelius-Flohé, R.; Aumann, K.D.; Roveri, A.; Schomburg, D.; Flohé, L. 
Diversity of glutathione peroxidases. Methods Enzymol. 1995, 252, 38–53. 
40. Labunskyy, V.M.; Hatfield, D.L.; Gladyshev, V.N. Selenoproteins: Molecular pathways and 
physiological roles. Physiol. Rev. 2014, 94, 739–777. 
41. Galano, A.; Alvarez-Idaboy, J.R. Glutathione: Mechanism and kinetics of its non-enzymatic 
defense action against free radicals. RSC Adv. 2011, 1, 1763–1771. 
42. Haenen, G.R.M.M.; Bast, A. Glutathione revisited: A better scavenger than previously thought. 
Front. Pharmacol. 2014, doi:10.3389/fphar.2014.00260. 
43. Stadtman, E.R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and 
by metal-catalyzed reactions. Annu. Rev. Biochem. 1993, 62, 797–821. 
44. Lee, B.C.; Gladyshev, V.N. The biological significance of methionine sulfoxide stereochemistry. 
Free Radic. Biol. Med. 2011, 50, 221–227. 
Biomolecules 2015, 5 2117 
 
 
45. Boschi-Muller, S.; Olry, A.; Antoine, M.; Branlant, G. The enzymology and biochemistry of 
methionine sulfoxide reductases. Biochim. Biophys. Acta 2005, 1703, 231–238. 
46. Lin, Z.; Johnson, L.C.; Weissbach, H.; Brot, N.; Lively, M.O.; Lowther, W.T. Free  
methionine-(R)-sulfoxide reductase from Escherichia coli reveals a new GAF domain function. 
Proc. Natl. Acad. Sci. USA 2007, 104, 9597–9602. 
47. Le, D.T.; Lee, B.C.; Marino, S.M.; Zhang, Y.; Fomenko, D.E.; Kaya, A.; Hacioglu, E.; Kwak, G.-H.; 
Koc, A.; Kim, H.-Y.; et al. Functional analysis of free methionine-R-sulfoxide reductase from 
Saccharomyces cerevisiae. J. Biol. Chem. 2009, 284, 4354–4364. 
48. Le, D.T.; Tarrago, L.; Watanabe, Y.; Kaya, A.; Lee, B.C.; Tran, U.; Nishiyama, R.; Fomenko, D.E.; 
Gladyshev, V.N.; Tran, L.-S.P. Diversity of plant methionine sulfoxide reductases B and evolution 
of a form specific for free methionine sulfoxide. PLoS ONE 2013, 8, e65637. 
49. Heurlier, K.; Vendeville, A.; Halliday, N.; Green, A.; Winzer, K.; Tang, C.M.; Hardie, K.R. 
Growth deficiencies of Neisseria meningitidis pfs and luxS mutants are not due to inactivation of 
quorum sensing. J. Bacteriol. 2009, 191, 1293–1302. 
50. Lyu, L.-D.; Tang, B.-K.; Fan, X.-Y.; Ma, H.; Zhao, G.-P. Mycobacterial MazG safeguards genetic 
stability via housecleaning of 5-OH-dCTP. PLoS Pathog. 2013, 9, e1003814. 
51. Van Schaftingen, E.; Rzem, R.; Veiga-da-Cunha, M. L-2-Hydroxyglutaric aciduria, a disorder of 
metabolite repair. J. Inherit. Metab. Dis. 2009, 32, 135–142. 
52. Nakabeppu, Y. Cellular levels of 8-oxoguanine in either DNA or the nucleotide pool play pivotal 
roles in carcinogenesis and survival of cancer cells. Int. J. Mol. Sci. 2014, 15, 12543–12557. 
53. Marinaki, A.M.; Duley, J.A.; Arenas, M.; Ansari, A.; Sumi, S.; Lewis, C.M.; Shobowale-Bakre, M.; 
Fairbanks, L.D.; Sanderson, J. Mutation in the ITPA gene predicts intolerance to azathioprine. 
Nucleosides. Nucleotides Nucleic Acids 2004, 23, 1393–1397. 
54. Sakamoto, T.; Maebayashi, K.; Nakagawa, Y.; Imai, H. Deletion of the four phospholipid 
hydroperoxide glutathione peroxidase genes accelerates aging in Caenorhabditis elegans. Genes Cells 
2014, 19, 778–792. 
55. Inoué, S.; Honda, K.; Komoda, Y. Sleep as neuronal detoxification and restitution. Behav. Brain Res. 
1995, 69, 91–96. 
56. Delaney, S.; Jarem, D.A.; Volle, C.B.; Yennie, C.J. Chemical and biological consequences of 
oxidatively damaged guanine in DNA. Free Radic. Res. 2012, 46, 420–441. 
57. Kamiya, H. Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen 
species: Approaches using synthetic oligonucleotides and nucleotides: Survey and summary. 
Nucleic Acids Res. 2003, 31, 517–531. 
58. Bessman, M.J.; Frick, D.N.; O’Handley, S.F. The MutT proteins or “Nudix” hydrolases, a family 
of versatile, widely distributed, “housecleaning” enzymes. J. Biol. Chem. 1996, 271, 25059–25062. 
59. Sekiguchi, M.; Tsuzuki, T. Oxidative nucleotide damage: Consequences and prevention. Oncogene 
2002, 21, 8895–8904. 
60. McLennan, A.G. The Nudix hydrolase superfamily. Cell. Mol. Life Sci. 2006, 63, 123–143. 
61. Persson, R.; Cedergren-Zeppezauer, E.S.; Wilson, K.S. Homotrimeric dUTPases; structural 
solutions for specific recognition and hydrolysis of dUTP. Curr. Protein Pept. Sci. 2001, 2, 287–300. 
62. Hemsworth, G.R.; González-Pacanowska, D.; Wilson, K.S. On the catalytic mechanism of dimeric 
dUTPases. Biochem. J. 2013, 456, 81–88. 
Biomolecules 2015, 5 2118 
 
 
63. Marbaix, A.Y.; Noël, G.; Detroux, A.M.; Vertommen, D.; van Schaftingen, E.; Linster, C.L. 
Extremely conserved ATP- or ADP-dependent enzymatic system for nicotinamide nucleotide repair. 
J. Biol. Chem. 2011, 286, 41246–41252. 
64. Oppenheimer, N.J.; Kaplan, N.O. Glyceraldehyde-3-phosphate dehydrogenase catalyzed hydration 
of the 5–6 double bond of reduced -nicotinamide adenine dinucleotide (NADH). Formation of  
-6-hydroxy-1,4,5,6-tetrahydronicotinamide adenine dinucleotide. Biochemistry 1974, 13, 4685–4694. 
65. Yoshida, A.; Dave, V. Inhibition of NADP-dependent dehydrogenases by modified products of 
NADPH. Arch. Biochem. Biophys. 1975, 169, 298–303. 
66. Niehaus, T.D.; Richardson, L.G.L.; Gidda, S.K.; ElBadawi-Sidhu, M.; Meissen, J.K.; Mullen, R.T.; 
Fiehn, O.; Hanson, A.D. Plants utilize a highly conserved system for repair of NADH and NADPH 
hydrates. Plant Physiol. 2014, 165, 52–61. 
67. Colinas, M.; Shaw, H.V.; Loubéry, S.; Kaufmann, M.; Moulin, M.; Fitzpatrick, T.B. A pathway 
for repair of NAD(P)H in plants. J. Biol. Chem. 2014, 289, 14692–14706. 
68. Marbaix, A.Y.; Tyteca, D.; Niehaus, T.D.; Hanson, A.D.; Linster, C.L.; van Schaftingen, E. 
Occurrence and subcellular distribution of the NADPHX repair system in mammals. Biochem. J. 
2014, 460, 49–58. 
69. Keller, M.A.; Piedrafita, G.; Ralser, M. The widespread role of non-enzymatic reactions in cellular 
metabolism. Curr. Opin. Biotechnol. 2015, 34, 153–161. 
70. D’Ari, R.; Casadesús, J. Underground metabolism. Bioessays 1998, 20, 181–186. 
71. Keller, M.A.; Turchyn, A.V.; Ralser, M. Non-enzymatic glycolysis and pentose phosphate pathway-like 
reactions in a plausible Archean ocean. Mol. Syst. Biol. 2014, doi:10.1002/msb.20145228. 
72. Weinert, B.T.; Iesmantavicius, V.; Moustafa, T.; Schölz, C.; Wagner, S.A.; Magnes, C.; Zechner, R.; 
Choudhary, C. Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol. Syst. Biol. 
2014, doi:10.1002/msb.134766. 
73. Wagner, G.R.; Payne, R.M. Widespread and enzyme-independent N-acetylation and  
N-succinylation of proteins in the chemical conditions of the mitochondrial matrix. J. Biol. Chem. 
2013, 288, 29036–29045. 
74. Wagner, G.R.; Hirschey, M.D. Nonenzymatic protein acylation as a carbon stress regulated by 
sirtuin deacylases. Mol. Cell 2014, 54, 5–16. 
75. Zhang, Y.; Xiao, M.; Horiyama, T.; Zhang, Y.; Li, X.; Nishino, K.; Yan, A. The multidrug  
efflux pump MdtEF protects against nitrosative damage during the anaerobic respiration in 
Escherichia coli. J. Biol. Chem. 2011, 286, 26576–26584. 
76. Zhou, K.; Zou, R.; Stephanopoulos, G.; Too, H.-P. Metabolite profiling identified methylerythritol 
cyclodiphosphate efflux as a limiting step in microbial isoprenoid production. PLoS ONE 2012,  
7, e47513. 
77. Fung, D.K.C.; Lau, W.Y.; Chan, W.T.; Yan, A. Copper efflux is induced during anaerobic  
amino acid limitation in Escherichia coli to protect iron-sulfur cluster enzymes and biogenesis.  
J. Bacteriol. 2013, 195, 4556–4568. 
78. Piddock, L.J.V. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in 
bacteria. Clin. Microbiol. Rev. 2006, 19, 382–402. 
79. Nikaido, H.; Zgurskaya, H.I. AcrAB and related multidrug efflux pumps of Escherichia coli.  
J. Mol. Microbiol. Biotechnol. 2001, 3, 215–218. 
80. Li, X.-Z.; Nikaido, H. Efflux-mediated drug resistance in bacteria: An update. Drugs 2009, 69, 
1555–1623. 
Biomolecules 2015, 5 2119 
 
 
81. Bleuel, C.; Grosse, C.; Taudte, N.; Scherer, J.; Wesenberg, D.; Krauss, G.J.; Nies, D.H.; Grass, G. 
TolC is involved in enterobactin efflux across the outer membrane of Escherichia coli. J. Bacteriol. 
2005, 187, 6701–6707. 
82. Du, D.; Wang, Z.; James, N.R.; Voss, J.E.; Klimont, E.; Ohene-Agyei, T.; Venter, H.; Chiu, W.; 
Luisi, B.F. Structure of the AcrAB-TolC multidrug efflux pump. Nature 2014, 509, 512–515. 
83. Takatsuka, Y.; Chen, C.; Nikaido, H. Mechanism of recognition of compounds of diverse structures 
by the multidrug efflux pump AcrB of Escherichia coli. Proc. Natl. Acad. Sci. USA 2010, 107, 
6559–6565. 
84. Poole, K. Bacterial multidrug efflux pumps serve other functions. Microbe 2008, 3, 179–185. 
85. Deininger, K.N.W.; Horikawa, A.; Kitko, R.D.; Tatsumi, R.; Rosner, J.L.; Wachi, M.; 
Slonczewski, J.L. A requirement of TolC and MDR efflux pumps for acid adaptation and GadAB 
induction in Escherichia coli. PLoS ONE 2011, 6, e18960. 
86. Tatsumi, R.; Wachi, M. TolC-dependent exclusion of porphyrins in Escherichia coli. J. Bacteriol. 
2008, 190, 6228–6233. 
87. Rosner, J.L.; Martin, R.G. Reduction of cellular stress by TolC-dependent efflux pumps in 
Escherichia coli indicated by BaeSR and CpxARP activation of spy in efflux mutants. J. Bacteriol. 
2013, 195, 1042–1050. 
88. Nagy, P.; Lechte, T.P.; Das, A.B.; Winterbourn, C.C. Conjugation of glutathione to oxidized 
tyrosine residues in peptides and proteins. J. Biol. Chem. 2012, 287, 26068–26076. 
89. Bar-Even, A.; Noor, E.; Savir, Y.; Liebermeister, W.; Davidi, D.; Tawfik, D.S.; Milo, R. The 
moderately efficient enzyme: Evolutionary and physicochemical trends shaping enzyme parameters. 
Biochemistry 2011, 50, 4402–4410. 
90. Khersonsky, O.; Tawfik, D.S. Enzyme promiscuity: A mechanistic and evolutionary perspective. 
Annu. Rev. Biochem. 2010, 79, 471–505. 
91. Hult, K.; Berglund, P. Enzyme promiscuity: Mechanism and applications. Trends Biotechnol. 
2007, 25, 231–238. 
92. Copley, S.D. Enzymes with extra talents: Moonlighting functions and catalytic promiscuity.  
Curr. Opin. Chem. Biol. 2003, 7, 265–272. 
93. Bensaad, K.; Tsuruta, A.; Selak, M.A.; Vidal, M.N.C.; Nakano, K.; Bartrons, R.; Gottlieb, E.; 
Vousden, K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126, 
107–120. 
94. Gerin, I.; Noël, G.; Bolsée, J.; Haumont, O.; van Schaftingen, E.; Bommer, G.T. Identification of 
TP53-induced glycolysis and apoptosis regulator (TIGAR) as the phosphoglycolate-independent 
2,3-bisphosphoglycerate phosphatase. Biochem. J. 2014, 458, 439–448. 
95. Yebra, M.J.; Bhagwat, A.S. A cytosine methyltransferase converts 5-methylcytosine in DNA to 
thymine. Biochemistry 1995, 34, 14752–14757. 
96. Engqvist, M.K.M.; Eßer, C.; Maier, A.; Lercher, M.J.; Maurino, V.G. Mitochondrial 2-hydroxyglutarate 
metabolism. Mitochondrion 2014, 19, 275–281. 
97. Ward, P.S.; Patel, J.; Wise, D.R.; Abdel-Wahab, O.; Bennett, B.D.; Coller, H.A.; Cross, J.R.; 
Fantin, V.R.; Hedvat, C.V.; Perl, A.E.; et al. The common feature of leukemia-associated IDH1 and 
IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. 
Cancer Cell 2010, 17, 225–234. 
Biomolecules 2015, 5 2120 
 
 
98. Struys, E.A.; Salomons, G.S.; Achouri, Y.; van Schaftingen, E.; Grosso, S.; Craigen, W.J.; 
Verhoeven, N.M.; Jakobs, C. Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause  
D-2-hydroxyglutaric aciduria. Am. J. Hum. Genet. 2005, 76, 358–360. 
99. Kranendijk, M.; Struys, E.A.; van Schaftingen, E.; Gibson, K.M.; Kanhai, W.A.; van der Knaap, M.S.; 
Amiel, J.; Buist, N.R.; Das, A.M.; de Klerk, J.B.; et al. IDH2 mutations in patients with  
D-2-hydroxyglutaric aciduria. Science 2010, doi:10.1126/science.1192632. 
100. Sobota, J.M.; Imlay, J.A. Iron enzyme ribulose-5-phosphate 3-epimerase in Escherichia coli is 
rapidly damaged by hydrogen peroxide but can be protected by manganese. Proc. Natl. Acad. Sci. USA 
2011, 108, 5402–5407. 
101. Anjem, A.; Imlay, J.A. Mononuclear iron enzymes are primary targets of hydrogen peroxide stress. 
J. Biol. Chem. 2012, 287, 15544–15556. 
102. Cotruvo, J.A.; Stubbe, J. Metallation and mismetallation of iron and manganese proteins in vitro 
and in vivo: The class I ribonucleotide reductases as a case study. Metallomics 2012, 4, 1020–1036. 
103. Frawley, E.R.; Fang, F.C. The ins and outs of bacterial iron metabolism. Mol. Microbiol. 2014, 93, 
609–616. 
104. Barnese, K.; Gralla, E.B.; Valentine, J.S.; Cabelli, D.E. Biologically relevant mechanism for 
catalytic superoxide removal by simple manganese compounds. Proc. Natl. Acad. Sci. USA 2012, 
109, 6892–6897. 
105. Sanchez, R.J.; Srinivasan, C.; Munroe, W.H.; Wallace, M.A.; Martins, J.; Kao, T.Y.; Le, K.;  
Gralla, E.B.; Valentine, J.S. Exogenous manganous ion at millimolar levels rescues all known 
dioxygen-sensitive phenotypes of yeast lacking CuZnSOD. J. Biol. Inorg. Chem. 2005, 10, 913–923. 
106. Copley, S.D. Toward a systems biology perspective on enzyme evolution. J. Biol. Chem. 2012, 
287, 3–10. 
107. Söll, D. Enter a new amino acid. Nature 1988, 331, 662–663. 
108. Prat, L.; Heinemann, I.U.; Aerni, H.R.; Rinehart, J.; O’Donoghue, P.; Söll, D. Carbon  
source-dependent expansion of the genetic code in bacteria. Proc. Natl. Acad. Sci. USA 2012, 109, 
21070–21075. 
109. Li, L.; Boniecki, M.T.; Jaffe, J.D.; Imai, B.S.; Yau, P.M.; Luthey-Schulten, Z.A.; Martinis, S.A. 
Naturally occurring aminoacyl-tRNA synthetases editing-domain mutations that cause mistranslation 
in Mycoplasma parasites. Proc. Natl. Acad. Sci. USA 2011, 108, 9378–9383. 
110. Netzer, N.; Goodenbour, J.M.; David, A.; Dittmar, K.A.; Jones, R.B.; Schneider, J.R.; Boone, D.; 
Eves, E.M.; Rosner, M.R.; Gibbs, J.S.; et al. Innate immune and chemically triggered oxidative 
stress modifies translational fidelity. Nature 2009, 462, 522–526. 
111. Lee, J.Y.; Kim, D.G.; Kim, B.-G.; Yang, W.S.; Hong, J.; Kang, T.; Oh, Y.S.; Kim, K.R.; Han, B.W.; 
Hwang, B.J.; et al. Promiscuous methionyl-tRNA synthetase mediates adaptive mistranslation to 
protect cells against oxidative stress. J. Cell Sci. 2014, 127, 4234–4245. 
112. Bender, A.; Hajieva, P.; Moosmann, B. Adaptive antioxidant methionine accumulation in respiratory 
chain complexes explains the use of a deviant genetic code in mitochondria. Proc. Natl. Acad. Sci. 
USA 2008, 105, 16496–16501. 
113. Miranda, I.; Silva-Dias, A.; Rocha, R.; Teixeira-Santos, R.; Coelho, C.; Gonçalves, T.; Santos, M.A.S.; 
Pina-Vaz, C.; Solis, N.V.; Filler, S.G.; et al. Candida albicans CUG mistranslation is a mechanism 
to create cell surface variation. MBio 2013, 4, doi:10.1128/mBio.00285-13. 
Biomolecules 2015, 5 2121 
 
 
114. Lal, P.B.; Schneider, B.L.; Vu, K.; Reitzer, L. The redundant aminotransferases in lysine and 
arginine synthesis and the extent of aminotransferase redundancy in Escherichia coli. Mol. Microbiol. 
2014, 94, 843–856. 
115. Miranda, I.; Rocha, R.; Santos, M.C.; Mateus, D.D.; Moura, G.R.; Carreto, L.; Santos, M.A.S.  
A genetic code alteration is a phenotype diversity generator in the human pathogen Candida albicans. 
PLoS ONE 2007, 2, e996. 
116. Rothstein, M. Aging and the alteration of enzymes: A review. Mech. Ageing Dev. 1975, 4, 325–338. 
117. Van Montfort, R.L.M.; Congreve, M.; Tisi, D.; Carr, R.; Jhoti, H. Oxidation state of the active-site 
cysteine in protein tyrosine phosphatase 1B. Nature 2003, 423, 773–777. 
118. Lee, J.-G.; Baek, K.; Soetandyo, N.; Ye, Y. Reversible inactivation of deubiquitinases by reactive 
oxygen species in vitro and in cells. Nat. Commun. 2013, doi:10.1038/ncomms2532. 
119. Ralser, M.; Wamelink, M.M.; Kowald, A.; Gerisch, B.; Heeren, G.; Struys, E.A.; Klipp, E.;  
Jakobs, C.; Breitenbach, M.; Lehrach, H.; et al. Dynamic rerouting of the carbohydrate flux is key 
to counteracting oxidative stress. J. Biol. 2007, doi:10.1186/jbiol61. 
120. Ralser, M.; Wamelink, M.M.C.; Latkolik, S.; Jansen, E.E.W.; Lehrach, H.; Jakobs, C. Metabolic 
reconfiguration precedes transcriptional regulation in the antioxidant response. Nat. Biotechnol. 
2009, 27, 604–605. 
121. Stincone, A.; Prigione, A.; Cramer, T.; Wamelink, M.M.C.; Campbell, K.; Cheung, E.;  
Olin-Sandoval, V.; Gruening, N.-M.; Krueger, A.; Tauqeer Alam, M.; et al. The return of metabolism: 
Biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 2015, 
90, 927–963. 
122. Peralta, D.; Bronowska, A.K.; Morgan, B.; Dóka, É.; van Laer, K.; Nagy, P.; Gräter, F.; Dick, T.P. 
A proton relay enhances H2O2 sensitivity of GAPDH to facilitate metabolic adaptation. Nat. Chem. 
Biol. 2015, 11, 156–163. 
123. Ralser, M.; Heeren, G.; Breitenbach, M.; Lehrach, H.; Krobitsch, S. Triose phosphate isomerase 
deficiency is caused by altered dimerization—Not catalytic inactivity—Of the mutant enzymes. 
PLoS ONE 2006, 1, e30. 
124. Grüning, N.-M.; Du, D.; Keller, M.A.; Luisi, B.F.; Ralser, M. Inhibition of triosephosphate 
isomerase by phosphoenolpyruvate in the feedback-regulation of glycolysis. Open Biol. 2014,  
doi:10.1098/rsob.130232. 
125. Grüning, N.-M.; Rinnerthaler, M.; Bluemlein, K.; Mülleder, M.; Wamelink, M.M.C.; Lehrach, H.; 
Jakobs, C.; Breitenbach, M.; Ralser, M. Pyruvate kinase triggers a metabolic feedback loop that 
controls redox metabolism in respiring cells. Cell Metab. 2011, 14, 415–427. 
126. Kuehne, A.; Emmert, H.; Soehle, J.; Winnefeld, M.; Fischer, F.; Wenck, H.; Gallinat, S.;  
Terstegen, L.; Lucius, R.; Hildebrand, J.; et al. Acute activation of oxidative pentose phosphate 
pathway as first-line response to oxidative stress in human skin cells. Mol. Cell 2015, 
doi:10.1016/j.molcel.2015.06.017. 
127. Fan, J.; Ye, J.; Kamphorst, J.J.; Shlomi, T.; Thompson, C.B.; Rabinowitz, J.D. Quantitative flux 
analysis reveals folate-dependent NADPH production. Nature 2014, 510, 298–302. 
128. Miller-Fleming, L.; Olin-Sandoval, V.; Campbell, K.; Ralser M. Remaining mysteries of molecular 
biology: The role of polyamines in the cell. J. Mol. Biol. 2015, doi:10.1016/j.jmb.2015.06.020. 
Biomolecules 2015, 5 2122 
 
 
129. Krüger, A.; Vowinckel, J.; Mülleder, M.; Grote, P.; Capuano, F.; Bluemlein, K.; Ralser, M.  
Tpo1-mediated spermine and spermidine export controls cell cycle delay and times antioxidant 
protein expression during the oxidative stress response. EMBO Rep. 2013, 14, 1113–1119. 
130. Casero, R.A.; Pegg, A.E. Polyamine catabolism and disease. Biochem. J. 2009, 421, 323–338. 
131. Pledgie, A.; Huang, Y.; Hacker, A.; Zhang, Z.; Woster, P.M.; Davidson, N.E.; Casero, R.A. 
Spermine oxidase SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary source of 
cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines. J. Biol. Chem. 2005, 
280, 39843–39851. 
132. Bianchi, M.; Bellini, A.; Cervelli, M.; Degan, P.; Marcocci, L.; Martini, F.; Scatteia, M.; Mariottini, P.; 
Amendola, R. Chronic sub-lethal oxidative stress by spermine oxidase overactivity induces continuous 
DNA repair and hypersensitivity to radiation exposure. Biochim. Biophys. Acta 2007, 1773, 774–783. 
133. Amendola, R.; Cervelli, M.; Fratini, E.; Sallustio, D.E.; Tempera, G.; Ueshima, T.; Mariottini, P.; 
Agostinelli, E. Reactive oxygen species spermine metabolites generated from amine oxidases and 
radiation represent a therapeutic gain in cancer treatments. Int. J. Oncol. 2013, 43, 813–820. 
134. Carbonell, P.; Lecointre, G.; Faulon, J.-L. Origins of specificity and promiscuity in metabolic 
networks. J. Biol. Chem. 2011, 286, 43994–44004. 
135. Jensen, R.A. Enzyme recruitment in evolution of new function. Annu. Rev. Microbiol. 1976, 30, 409–425. 
136. Voordeckers, K.; Brown, C.A.; Vanneste, K.; van der Zande, E.; Voet, A.; Maere, S.; Verstrepen, K.J. 
Reconstruction of ancestral metabolic enzymes reveals molecular mechanisms underlying evolutionary 
innovation through gene duplication. PLoS Biol. 2012, 10, e1001446. 
137. Notebaart, R.A.; Szappanos, B.; Kintses, B.; Pal, F.; Gyorkei, A.; Bogos, B.; Lazar, V.; Spohn, R.; 
Csorg, B.; Wagner, A.; et al. Network-level architecture and the evolutionary potential of underground 
metabolism. Proc. Natl. Acad. Sci. USA 2014, 111, 11762–11767. 
138. Cornish-Bowden, A.; Cardenas, M.L. Self-organization at the origin of life. J. Theor. Biol. 2008, 
252, 411–418. 
139. Piedrafita, G.; Montero, F.; Morán, F.; Cárdenas, M.L.; Cornish-Bowden, A. A simple self-maintaining 
metabolic system: Robustness, autocatalysis, bistability. PLoS Comput. Biol. 2010, doi:10.1371/ 
journal.pcbi.1000872. 
140. Tawfik, D.S. Messy biology and the origins of evolutionary innovations. Nat. Chem. Biol. 2010, 
6, 692–696. 
141. Benoit, R.; Auer, M. A direct way of redox sensing. RNA Biol. 2011, 8, 18–23. 
142. Andersson, D.I. Evolving promiscuously. Proc. Natl. Acad. Sci. USA 2011, 108, 1199–1200. 
143. Miller, B.G.; Raines, R.T. Identifying latent enzyme activities: Substrate ambiguity within modern 
bacterial sugar kinases. Biochemistry 2004, 43, 6387–6392. 
144. Patrick, W.M.; Quandt, E.M.; Swartzlander, D.B.; Matsumura, I. Multicopy suppression underpins 
metabolic evolvability. Mol. Biol. Evol. 2007, 24, 2716–2722. 
145. Patrick, W.M.; Matsumura, I. A study in molecular contingency: Glutamine phosphoribosylpyrophosphate 
amidotransferase is a promiscuous and evolvable phosphoribosylanthranilate isomerase. J. Mol. Biol. 
2008, 377, 323–336. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
